Microsoft Word - RESTASIS PI Feb 04.doc
Cyclosporine 's chemical name is Cyclo[[( E)-( 2S, 3R, 4R)- 3- hydroxy- 4- methyl- 2-( methylamino)- 6- octenoyl]- L- 2- aminobutyryl- N- methylglycylN- methyl- L- leucyl- L- valyl- N- methyl- L- leucyl- L- alanyl- D- alanyl- N- methyl- L- leucyl- N- methyl- L- leucyl- N- methyl- L- valyl] and it has the following structure: Cyclosporine is a fine white powder. CLINICAL...
author: tran_ynhu
Microsoft Word - RESTASIS PI Feb 04.doc page 2
author: tran_ynhu
Microsoft Word - RESTASIS PI Feb 04.doc page 1
author: tran_ynhu
Cyclosporine ophthalmic for Sjoegren's syndrome - [Medication] - Quest Diagnostics Patient Health Library
Cyclosporine ophthalmic for Sjoegren's syndrome Examples Brand Name Chemical Name Restasis cyclosporine How It Works Cyclosporine is an immunosuppressive medication that decreases the action of your body's immune system.Cyclosporine ophthalmic is used in eyedrop form to treat Sjoegren's syndrome , a disease that causes dry eyes and mouth. ...
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...
CDER 2002 Report to the Nation; Drug Review
Food and Drug Administration Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2002 Table of Contents Adobe Acrobat version of this document 1 Drug Review Index Mission Highlights New Drug Review List of priority new drugs List of new molecular entities List of orphan new drugs New Drug Review Statistics Priority new drug statistics...
author: OLIVERN
Prescription and Over-the-Counter Drug Product List: 3/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc
NDA 50- 790/ S- 001 Page 3 RESTASIS (cyclosporine ophthalmic emulsion) 0.05% Sterile, Preservative- Free DESCRIPTION RESTASIS (cyclosporine ophthalmic emulsion) 0.05% contains a topical immunomodulator with anti- inflammatory effects INDICATIONS AND USAGE RESTASIS ophthalmic emulsion is indicated to increase tear production in patients whose tear production is...
author: Lori Gorski
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc page 4
author: Lori Gorski
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc page 3
author: Lori Gorski
C:\LORI\ALLERGAN\50790 slr001 AP ltr vial statement 8-8-03.doc page 1
author: Lori Gorski
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc
NDA 21- 023 Page 3 RESTASIS (cyclosporine ophthalmic emulsion) 0.05% Sterile, Preservative- Free DESCRIPTION RESTASIS (cyclosporine ophthalmic emulsion) 0.05% contains a topical immunomodulator with anti- inflammatory effects No increase in bacterial or fungal ocular infections was reported following administration of RESTASIS NDA 21- 023 Page 5 RESTASIS ...
author: Lori Gorski
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc page 4
author: Lori Gorski
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc page 3
author: Lori Gorski
C:\LORI\ALLERGAN\21023 AP ltr 12-23-02 with label final.doc page 1
author: Lori Gorski
Prescription and OTC Drug Product List 12/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACARBOSE TABLET; ORAL PRECOSE -D- BAYER 25MG N20482 004 MAY 29, 1997 DEC CAHN -D- 50MG N20482 001 SEP 06, 1995 DEC CAHN -D- + 100MG N20482 002 SEP 06, 1995 DEC CAHN -A- BAYER PHARMS 25MG N20482 004 MAY 29, 1997 DEC CAHN -A- 50MG N20482 001 SEP 06, 1995 DEC CAHN -A- + 100MG N20482 002 SEP 06, 1995 DEC CAHN ACYCLOVIR -A- CREAM;...
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]
Allergan
Skip to content Global Locations- Contact Us- Search- About Us- History Leadership Global Locations What We Treat- Eye Care: Dry Eye Glaucoma Other Eye Conditions Neurosciences: Blepharospasm Cervical Dystonia Strabismus Obesity Intervention Medical Aesthetics: Breast Aesthetics Facial Aesthetics Medical Dermatology: Acne Psoriasis Severe Primary Axillary Hyperhidrosis Other Skin...
author: PINT [ www.pint.com ]